🇺🇸 Krystal Biotech, Inc.
Forum topic · KRYS · Company page: financials, ownership and filings
Join the discussion on Krystal Biotech, Inc.
Loading…
Results announced on 2 November 2026
Krystal Biotech, Inc. announced results on 2 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $127 million (up 30% from a year earlier) and net income of $63 million (down 21% from a year earlier).
Mutual funds: 342 funds hold $5.3 billion
342 mutual funds in 2 countries hold shares of Krystal Biotech, Inc. worth $5.3 billion, about 50.4% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 211 funds added shares and 87 sold; on balance they bought $283 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.